Company Overview

Update
Headquarters:
Vancouver
Funding:
$0
Categories:
Biotechnology

Aurin biotech is a private corporation established to develop clinical applications of agents that can block self attack by aberrant

Description

Update

Aurin biotech is a private corporation established to develop clinical applications of agents that can block self attack by aberrant complement activation. Such attack has been reported to occur in many human diseases. Our lead compound is aurin tricarboxylic acid (ATA).

Current Team (2)

Update

Funding Rounds (1) - $0

Update
  • unknown amount

    Investors Unknown
    Dec 20, 2013 -Angel

Offices/Locations (1)

Update
  • Office

    4727 West Second Avenue

    Vancouver, V6T1C1

    CAN

Images (1)

Update
  • 021259c8e189ae84b3294920f5906e6c